The Guardian Hemostasis Valve exhibits the successful implementation of Zerusa's progressive business model. Guardian was developed through a collaborative partnership with a successful cardiologist and is designed to be the next generation hemostasis valve for all interventional procedures. More >>

Why We

Are Different

Our strength lies in developing close partnerships with our physician inventors, entrepreneurs or partner companies to identify and exploit an unmet need in the market. We work the front lines with the physicians in coronary cath labs, peripheral radiology labs and neuroradiology labs to understand physician needs, challenges and opportunities. We have the capability to realize those product improvements or new product ideas that larger medical device companies overlook. Yet, we are willing to work with those same companies to market our innovative technologies.

Product

Development Cycle

We leverage our collective knowledge and experience to support the research, development and distribution of our products. We are building value in the company by developing innovative, products which are unique, intellectual property based and address an unmet need in the market.

Recent News & Events

April 29, 2008

Zerusa Limited to attend EuroPCR 2008 course in Barcelona, Spain from May 13 to 16, 2008

Nov 10 , 2007

Zerusa Limited attends the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, DC, USA October 20 - 25, 2007

Sept 5 , 2007

Come see the new, innovative Guardian hemostasis valve at a number of United States medical conventions this fall 2007.  The Guardian will be on display at the booth of our US distribution partner, Vascular Solutions, Inc.